Current guidelines recommend that all hospitalized patients undergoing chemotherapy receive prophylactic antithrombotic treatment; outpatients should only receive said treatment if they are considered high-risk. The Khorana scale is used to assess the risk of venous thromboembolism, but its accuracy has recently been called into question.

The Vienna Cancer and Thrombosis ...